Related Experiment Video
Updated: Mar 21, 2026

07:54
Isolation of Neonatal Extrahepatic Cholangiocytes
Published on: June 5, 2014
10.9K
Cotoneaster: A Safe and Easy Way to Reduce Neonatal Jaundice
Mahmoud Rafieian-Kopaei1, Abolfazl Khoshdel2, Soleiman Kheiri3
1Professor, Medical Plants Research Center, Shahrekord University of Medical Sciences , Shahrekord, Iran .
Journal of Clinical and Diagnostic Research : JCDR
|May 19, 2016
Summary
Mothers consuming cotoneaster may help reduce neonatal jaundice. Combined maternal and infant cotoneaster consumption led to the quickest reduction in jaundice and shorter hospital stays.
Area of Science:
- Neonatal Medicine
- Pharmacology
Background:
- Neonatal jaundice is a common condition in newborns.
- Cotoneaster consumption has been anecdotally linked to reduced neonatal jaundice.
Purpose of the Study:
- To investigate the efficacy of cotoneaster in treating neonatal jaundice.
- To determine the impact of maternal cotoneaster intake on infant jaundice.
Main Methods:
- A randomized clinical trial involving 120 jaundiced neonates.
- Four groups: cotoneaster for both mother and neonate, mother only, neonate only, and placebo.
- Standard phototherapy was administered to all neonates.
Main Results:
- Treatment groups showed significantly higher bilirubin reduction compared to the control group.
- Maternal cotoneaster consumption led to lower bilirubin levels at 24 and 36 hours.
- The group receiving cotoneaster (both mother and neonate) exhibited the most significant bilirubin reduction.
Conclusions:
- Cotoneaster consumption by mothers and/or neonates can effectively reduce neonatal jaundice.
- Combined maternal and neonatal cotoneaster intake accelerated jaundice treatment and reduced hospitalization duration.
Related Concept Videos
Changes in Skin Color: Clinical Perspectives
4.1K
The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
4.1K
Teratogenicity
4.5K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.5K
Drug Dosing: Infants and Children
705
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
705
Pigmentation
4.9K
The color of the skin is influenced by a number of pigments, including melanin, carotene, and hemoglobin. Recall that melanin is produced by cells called melanocytes, which are found scattered throughout the stratum basale of the epidermis. The melanin is transferred to the keratinocytes via melanosomes.
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...
4.9K
Drug Toxicity: Allergic Reactions
126
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
126
Drug Toxicity: Risk factors
133
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
133

